Research Associate – Lab11 Therapeutics
Lab11 Therapeutics invites applications for part-time Research Associate, particularly interested in candidates with demonstrated academic excellence who are interested in contributing to research programs focused on developing novel treatment of viral diseases.
Why it matters: Researchers help Lab11 Therapeutics develop broad spectrum antivirals.
Lab11 Therapeutics invite applications for part-time Research Associate. We are particularly interested in candidates with demonstrated academic excellence who are interested in contributing to research programs focused on developing novel treatment of viral diseases.
Requirements:
Appointment as Research Associate will be commensurate with experience, training and achievements. Suitable candidates will have an BS, MS or M.D./Ph.D degrees (or their equivalents). Experience with mammalian cell culture is required; experience in virology and demonstrated ability to take initiative and work independently are a plus.
Applicants should submit a single PDF containing a cover letter, curriculum vitae, and contact information (name, address, phone, email) of four referees to dusan.bogunovic@lab11therapeutics.org.
About Lab11 Therapeutics LLC:
Lab11 Therapeutics LLC is a biotechnology company residing at JLABs DC located at Children’s National campus in Washington, DC. Lab11 Therapeutics develops broad spectrum antivirals. We have two separate and complementary programs. Program 1 is developing small-molecule broad spectrum antivirals. Program 2 is developing mRNA mediated delivery of host antiviral effectors, also serving as broad spectrum antivirals.
Jenny Zemel serves as Manager, Special Projects where she provides interdepartmental support on a variety of projects for both the NVCA team and Venture Forward team. She also helps support the administrative needs of NVCA’s President and CEO Bobby Franklin.